MediPal Holdings Corporation

MediPal Holdings Corporation

MEPDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.82B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MediPal Holdings CorporationMediPal Holdings Corporation15.22.42%7%-0.2
$41.46

Current Fair Value

122.2% upside

Undervalued by 122.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.82 Billion
Enterprise Value$-120,998,335,320.00
Annual dividend$0.49
Dividend yield2.42%
Earnings per Share$207.71
Beta-0.02
Outstanding Shares204,698,000

Return

Return on Equity7.15%ROE
Return on Assets2.23%
Return on Invested Capital9.18%

Valuation & Multiples

P/E Ratio15.2P/E Ratio
PEG-57.88PEG
Price to Sales0.0Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue-0.03
Enterprise Value to EBIT-1.96
Enterprise Value to Net Income-3
Total Debt to Enterprise-1.19
Debt to Equity0.23Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS
$0.29
Est. $0.44
Revenue
$6.23 B
Est. $6.26 B

Next Earnings Call

Expected Date
February 3, 2027
EPS Estimate
$0.47
Consensus analyst estimate
Revenue Estimate
$6.50 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About MediPal Holdings Corporation

13,024 employees
CEO: Shuichi Watanabe

Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, ...